Home › Device types › CCQ
Nebulizer, Medicinal, Non-Ventilatory (Atomizer)
FDA product code CCQ · Class 1 · Anesthesiology
250
Registered devices
623
Adverse events
9
Recalls
62
510(k) clearances
Devices with this code
N/A — SALTER LABSMedSource Nebulizer — MEDSOURCE INTERNATIONAL LLCCONTEC — Contec Medical Systems Co., Ltd.Salter AIRE Elite — SALTER LABSN/A — SALTER LABSLMA ATOMIZATION — TELEFLEX INCORPORATEDLMA ATOMIZATION — TELEFLEX INCORPORATEDSalter AIRE Elite — SALTER LABSN/A — SALTER LABSCenturion — CENTURION MEDICAL PRODUCTS CORPORATIONHUDSON RCI — TELEFLEX INCORPORATEDLMA ATOMIZATION — TELEFLEX INCORPORATEDMedSource Nebulizer — MEDSOURCE INTERNATIONAL LLCSURGYCO — Surgyco LLCLMA ATOMIZATION — TELEFLEX INCORPORATEDJEDMED — JEDMED INSTRUMENT COMPANYMediox — Mediox Medical Service LtdVixOne™ Nebulizer Kit — Canadian Hospital Specialties LimitedN/A — SALTER LABSN/A — SALTER LABSsilverfox — Silverfox Corporation LimitedVixOne™ Nebulizer Kit — Canadian Hospital Specialties LimitedDeVilbiss — DEVILBISS HEALTHCARE LLCLMA ATOMIZATION — TELEFLEX INCORPORATED
Recent recalls
| Date | Firm | Reason |
|---|---|---|
| 2016-10-27 | Teleflex Medical | Product Defect; These products may produce a straight stream instead of a fully atomized plume of medication. |
| 2016-10-27 | Teleflex Medical | Product Defect; These products may produce a straight stream instead of a fully atomized plume of medication. |
| 2016-10-27 | Teleflex Medical | Product Defect; These products may produce a straight stream instead of a fully atomized plume of medication. |
| 2016-10-27 | Teleflex Medical | Product Defect; These products may produce a straight stream instead of a fully atomized plume of medication. |
| 2016-10-27 | Teleflex Medical | Product Defect; These products may produce a straight stream instead of a fully atomized plume of medication. |
| 2013-04-30 | Nephron Pharmaceuticals Corp. | Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard. |
| 2013-04-30 | Nephron Pharmaceuticals Corp. | Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard. |
| 2013-04-30 | Nephron Pharmaceuticals Corp. | Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard. |
| 2011-03-25 | Salter Laboratories, Division of Regulatory Affairs | A small number of oxygen mask components were found to have 100% obstructed airways rendering them incapable of delivering oxygen to patients undergoing respira |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsSourced from public U.S. FDA data. Informational only — not medical or regulatory advice. Not affiliated with the FDA.